ARTICLE | Finance
Plus: Immunic eyes $240M private placement and updates from Applied Therapeutics and Novartis
By BioCentury Staff
January 6, 2024 2:52 AM UTC
Two more biotechs have filed to go public ahead of next week’s J.P. Morgan Healthcare Conference, marking the second and third companies of the year to aim for a NASDAQ listing: Metagenomi Inc., which is systematizing the search for new gene editing tools, and ArriVent Biopharma Inc., which is sourcing innovative products from China and developing them globally.
The largest shareholders of Emeryville, Calif.-based Metagenomi include Bayer HealthCare LLC, Humboldt Fund, ModernaTX Inc., Sake Holdings, Sozo Ventures and RA Capital; its offering is being underwritten by J.P. Morgan, Jefferies, TD Cowen, Wells Fargo Securities, BMO Capital Markets and Chardan. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651083/jan-5-quick-takes-metagenomi-arrivent-file-for-ipo